Black Patients Diagnosed with Aggressive Leukemia Experience Worse Outcomes, But Differences Not Linked to Key Genetic Changes

Compared with white patients, Black patients with an aggressive form of leukemia--called acute myeloid leukemia (AML)--were on average more than five years younger at diagnosis and more than 30 percent more likely to die of their disease; that is according to a new analysis of data led by University of Maryland School of Medicine researchers.

By |2025-12-19T10:56:03-05:00December 19, 2025|News & Updates, CPAN Latest Updates|

Blood Test May Help Identify Which Colon Cancer Patients Benefit From NSAIDs

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along with chemotherapy after surgery, according to new study in JAMA Oncology. Based on data from an Alliance for Clinical Trials in Oncology study, this finding could lead to more personalized treatments and better outcomes for patients.

By |2025-12-17T09:27:44-05:00December 17, 2025|CPAN Latest Updates, News & Updates|
Go to Top